US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 27, 2022 (4 years ago)

Ceftriaxone

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance

What was recalled

CEFTRIAXONE (a) 1GM IN NS 50ML, (b)4GM IN NS 200ML, (c) 8GM IN NS 400ML, antibiotic, Rx only, used in a Curlin or Home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,

Recalling firm
Sentara Infusion Services
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0282-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ceftriaxone recalls

See all
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-098-01 D-0620-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-097-02 D-0619-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-096-02 D-0618-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-095-02 D-0617-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-094-02 D-0616-2023